Friend or Foe? The Roles of Antioxidants in Acute Lung Injury

被引:20
|
作者
Liu, Yang [1 ]
Zhou, Shujun [2 ]
Xiang, Du [2 ]
Ju, Lingao [3 ,4 ]
Shen, Dexin [1 ]
Wang, Xinghuan [1 ]
Wang, Yanfeng [2 ]
机构
[1] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan 430071, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Inst Hepatobiliary Dis, Transplant Ctr, Wuhan 430071, Peoples R China
[3] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan 430071, Peoples R China
[4] Human Genet Resource Preservat Ctr Hubei Prov, Wuhan 430071, Peoples R China
关键词
acute lung injury; reactive oxygen species; oxygen radical; antioxidants; ACUTE RESPIRATORY-DISTRESS; HIGH-DOSE AMBROXOL; N-ACETYLCYSTEINE; VITAMIN-E; OXIDATIVE STRESS; FREE HEMOGLOBIN; MURINE MODEL; RAT LUNG; SUPPLEMENTATION; INFLAMMATION;
D O I
10.3390/antiox10121956
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Acute lung injury (ALI) is an acute hypoxic respiratory insufficiency caused by various intra- and extra-pulmonary injury factors. The oxidative stress caused by excessive reactive oxygen species (ROS) produced in the lungs plays an important role in the pathogenesis of ALI. ROS is a "double-edged sword", which is widely involved in signal transduction and the life process of cells at a physiological concentration. However, excessive ROS can cause mitochondrial oxidative stress, leading to the occurrence of various diseases. It is well-known that antioxidants can alleviate ALI by scavenging ROS. Nevertheless, more and more studies found that antioxidants have no significant effect on severe organ injury, and may even aggravate organ injury and reduce the survival rate of patients. Our study introduces the application of antioxidants in ALI, and explore the mechanisms of antioxidants failure in various diseases including it.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Friend or Foe: The Paradoxical Roles of MG53 in Diabetes
    Yuan, Shuangshuang
    Yu, Qin
    Luo, Mao
    Wu, Jianbo
    Wang, Liqun
    DIABETES, 2025, 74 (02) : 145 - 152
  • [42] Friend or Foe: Prognostic and Immunotherapy Roles of BTLA in Colorectal Cancer
    Song, Jingjing
    Wu, Lihui
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
  • [43] Neutrophils in traumatic brain injury (TBI): friend or foe?
    Liu, Yang-Wuyue
    Li, Song
    Dai, Shuang-Shuang
    JOURNAL OF NEUROINFLAMMATION, 2018, 15
  • [44] Autophagy in myocardial ischemia reperfusion injury: Friend or foe?
    Li, Tai
    Jiao, Yue-Ru
    Wang, Lan-Hua
    Zhou, Yan-Hong
    Yao, Heng-Chen
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 239 : 10 - 10
  • [45] Therapeutic physical exercise in neural injury: friend or foe?
    Park, Kanghui
    Lee, Seunghoon
    Hong, Yunkyung
    Park, Sookyoung
    Choi, Jeonghyun
    Chang, Kyu-Tae
    Kim, Joo-Heon
    Hong, Yonggeun
    JOURNAL OF PHYSICAL THERAPY SCIENCE, 2015, 27 (12) : 3933 - 3935
  • [46] Neutrophils in traumatic brain injury (TBI): friend or foe?
    Yang-Wuyue Liu
    Song Li
    Shuang-Shuang Dai
    Journal of Neuroinflammation, 15
  • [47] Rituximab and lupus interstitial lung disease: friend or foe?
    Efthimiou, Petros
    Kukar, Manil
    Hersh, Alissa
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2011, 14 (01) : E3 - E4
  • [48] IL-17 in lung disease: friend or foe?
    Tan, Hui-Leng
    Rosenthal, Mark
    THORAX, 2013, 68 (08) : 788 - 790
  • [49] Vascular endothelial growth factor of the lung: friend or foe
    Tuder, Rubin M.
    Yun, Jeong H.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (03) : 255 - 260
  • [50] Retinoids in lung cancer: Friend, foe, or fellow traveler?
    Khuri, FR
    Lotan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (17) : 3435 - 3437